Patent Assignment
Reel/Frame 070407/0632
Assignment of Assignor's Interest
Recorded: 2025-03-05
Pages: 3
Assignor
SCHIFFMAN, RHETT
Executed: 2022-11-05
Assignee
VISUS THERAPEUTICS, INC.
2 NICKERSON STREET SUITE 101, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Formulations Comprising Carbachol and Brimonidine to Enhance Anti-Presbyopia Effects
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Mar 20, 2024
From: VISUS THERAPEUTICS, INC.
To: LSP 6 HOLDING C.V., AS COLLATERAL AGENT
Reel/Frame 066839/0679 →
Assignment of Assignor's Interest
Mar 5, 2025
From: FIRESTONE, BRUCE
To: PHARMASSIST CMC CONSULTING, LLC
Reel/Frame 070407/0590 →
Assignment of Assignor's Interest
Mar 5, 2025
From: PHARMASSIST CMC CONSULTING, LLC
To: VISUS THERAPEUTICS, INC.
Reel/Frame 070407/0593 →
Release of Security Interest Reel 066839, Frame 0679
Dec 31, 2025
From: LSP 6 HOLDING C.V., AS COLLATERAL AGENT
To: VISUS THERAPEUTICS, INC.
Reel/Frame 074145/0450 →
Security Interest
Jan 9, 2026
From: TENPOINT THERAPEUTICS HOLDING LIMITED; TENPOINT THERAPEUTICS LIMITED; VISUS THERAPEUTICS, INC.; TENPOINT THERAPEUTICS INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 073417/0714 →